Authors: Gilbert, J Baker, SD Bowling, MK Grochow, L Figg, WD Zabelina, Y Donehower, RC Carducci, MA

Citation: J. Gilbert et al., A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies, CLIN CANC R, 7(8), 2001, pp. 2292-2300

Authors: Ratner, L Lee, J Tang, SH Redden, D Hamzeh, F Herndier, B Scadden, D Kaplan, L Ambinder, R Levine, A Harrington, W Grochow, L Flexner, C Tan, B Straus, D

Citation: L. Ratner et al., Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy, J CL ONCOL, 19(8), 2001, pp. 2171-2178

Authors: Jaffee, EM Hruban, RH Biedrzycki, B Laheru, D Schepers, K Sauter, PR Goemann, M Coleman, J Grochow, L Donehower, RC Lillemoe, KD O'Reilly, S Abrams, RA Pardoll, DM Cameron, JL Yeo, CJ

Citation: Em. Jaffee et al., Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immuneactivation, J CL ONCOL, 19(1), 2001, pp. 145-156

Authors: Hahm, HA Armstrong, DK Chen, TL Grochow, L Passos-Coelho, J Goodman, SN Davidson, NE Kennedy, MJ

Citation: Ha. Hahm et al., Novobiocin in combination with high-dose chemotherapy for the treatment ofadvanced breast cancer: A phase 2 study, BIOL BLOOD, 6(3A), 2000, pp. 335-343